Anthera totals $38m from public offering
This article was originally published in Scrip
Executive Summary
Anthera Pharmaceuticals' brokers have sold an extra 4.95 million shares of common stock at $1 a share, exercising in full their over-allotments. The completed public offering thus raised a total of $37.95 million for the Hayward, California firm.